Considering that Titin gene mutations, which disrupt its proper maturation, underly nearly every fourth case of congenital DCM when the causative mutation can be identified,289 these findings appear to be of potential therapeutic interest. This evidence concerns the gene TTN and familial dilated cardiomyopathy.